Foresee Pharmaceuticals Co Stock Price To Book
| 6576 Stock | TWD 73.70 0.10 0.14% |
Foresee Pharmaceuticals Co fundamentals help investors to digest information that contributes to Foresee Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Foresee Stock. The fundamental analysis module provides a way to measure Foresee Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Foresee Pharmaceuticals stock.
Foresee |
Foresee Pharmaceuticals Co Company Price To Book Analysis
Foresee Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Foresee Pharmaceuticals Price To Book | 10.24 X |
Most of Foresee Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Foresee Pharmaceuticals Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Foresee Pharmaceuticals Co has a Price To Book of 10.2367 times. This is 60.14% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to book for all Taiwan stocks is 7.64% lower than that of the firm.
Foresee Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Foresee Pharmaceuticals' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Foresee Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Foresee Pharmaceuticals by comparing valuation metrics of similar companies.Foresee Pharmaceuticals is currently under evaluation in price to book category among its peers.
Foresee Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | (1.57) % | |||
| Operating Margin | (1.57) % | |||
| Current Valuation | 10.39 B | |||
| Shares Outstanding | 118.12 M | |||
| Shares Owned By Insiders | 35.40 % | |||
| Shares Owned By Institutions | 3.14 % | |||
| Price To Book | 10.24 X | |||
| Price To Sales | 39.29 X | |||
| Revenue | 226.03 M | |||
| Gross Profit | 175.08 M | |||
| EBITDA | (475.83 M) | |||
| Net Income | (569.27 M) | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 11.47 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 18.76 X | |||
| Book Value Per Share | 9.36 X | |||
| Cash Flow From Operations | (213.33 M) | |||
| Earnings Per Share | (4.53) X | |||
| Target Price | 110.0 | |||
| Number Of Employees | 29 | |||
| Beta | 1.42 | |||
| Market Capitalization | 12.58 B | |||
| Total Asset | 1.64 B | |||
| Net Asset | 1.64 B |
About Foresee Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Foresee Pharmaceuticals Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Foresee Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Foresee Pharmaceuticals Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Foresee Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Foresee Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Foresee Stock
Moving against Foresee Stock
| 0.62 | 2345 | Accton Technology Corp | PairCorr |
| 0.57 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.55 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.46 | 0053 | YuantaP shares Taiwan | PairCorr |
| 0.43 | 1591 | Inmax Holding | PairCorr |
The ability to find closely correlated positions to Foresee Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Foresee Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Foresee Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Foresee Pharmaceuticals Co to buy it.
The correlation of Foresee Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Foresee Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Foresee Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Foresee Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.